## min read

Most Effective Treatment for Bipolar Disorder

|

November 3, 2026

Summarize with AI

Most Effective Treatment for Bipolar Disorder

Last updated: November 2026.

The most effective treatment for bipolar disorder is usually a combination of medication and psychotherapy, matched to the phase of the illness and continued over the long term. That's the answer most people are looking for, and it is supported by the reviews cited here. According to the National Institute of Mental Health (NIMH), bipolar disorder "usually requires lifelong treatment," but an effective plan helps people manage symptoms and improve their quality of life. A 2013 review in The Lancet by Geddes and Miklowitz organizes the evidence the same way: medication for acute episodes and prevention, with psychological treatment added on top. If you or someone you love was just diagnosed, or just went through a relapse, this guide walks through what each part does and why it matters. You can also read how we approach bipolar disorder treatment at Amae.

What "effective" means when you have bipolar disorder

Treatment has two jobs. The first is ending a current episode, whether that's mania, hypomania, depression, or an episode with mixed features (symptoms of both poles at once). The second, and the one that shapes the years ahead, is preventing the next episode.

Those jobs don't always call for the same tools. A medication that calms acute mania may not be the choice for bipolar depression, and the plan that works during a crisis often changes once mood settles. That's why the American Academy of Family Physicians (AAFP) review from 2021 splits treatment into acute mania, mixed features, acute depression, and maintenance. So when people ask about the best treatment for bipolar disorder, the real reply starts with a question back: best for which phase?

First-line treatment for bipolar disorder: medication by phase

Medication is the base of treatment for most people with bipolar disorder. The main classes are:

  • Mood stabilizers, including lithium and certain anticonvulsants. NIMH notes that some anticonvulsants work better than lithium for certain people, such as those with mixed symptoms or rapid cycling.
  • Atypical antipsychotics, used for mania, mixed episodes, and in some cases bipolar depression or maintenance.
  • Antidepressants, typically given alongside a mood stabilizer because of the risk of switching into mania.

The AAFP review describes mood stabilizers, including lithium, anticonvulsants, and antipsychotics, as a first-line treatment that "should be continued indefinitely because of the risk of patient relapse." Drug-by-drug detail, side effects, and pregnancy considerations are covered in our guide to how mood stabilizers work.

Treating a manic or mixed episode

Acute mania usually needs urgent care. The AAFP review says patients with acute mania require hospitalization because of the risk of harm to themselves or others, and that early goals include adequate sleep and reducing psychotic symptoms; high-quality evidence supports mood stabilizers, including lithium, valproic acid, and antipsychotics. For mixed features, the same review says antidepressants on their own are contraindicated.

Treating bipolar depression

Bipolar depression isn't treated the way Major Depressive Disorder is. An antidepressant on its own can tip some people into mania. For bipolar depression, NIMH says health care providers typically prescribe a mood stabilizer and an antidepressant together to reduce the risk of switching into mania. Some atypical antipsychotics are also used in this phase.

Long-term maintenance

This is where many plans fall apart. People feel well, the medication feels unnecessary, and they stop. Bipolar disorder is a relapsing illness: the AAFP review reports relapse in more than 70% of patients within five years, whatever the treatment, which is why it recommends continuing medication indefinitely. Any change to medication belongs in a conversation with the prescriber, never a quiet decision at home.

Lithium has the longest track record for maintenance. NIMH states that "some studies indicate that lithium may reduce the risk of suicide" among people taking it for long-term maintenance, and that people on lithium need regular monitoring of lithium levels and kidney and thyroid function.

When first options do not work

Some people don't respond to the first or second medication plan. Clinicians then adjust doses, combine medications, or look at other treatments. One of these is electroconvulsive therapy (ECT): the AAFP review states that ECT is effective for mania and psychotic depression. We include it here for education, not as a service we provide.

Therapies that work alongside medication

Medication steadies mood. Therapy builds the skills and routines that keep it steady. The main evidence-based options:

  • Psychoeducation teaches you and your family how the illness behaves, which early signs to watch, and what to do when they show up.
  • Cognitive behavioral therapy (CBT) works on the thoughts and habits that feed depressive episodes and on catching early warning signs.
  • Family-focused therapy brings relatives in to improve communication and plan for relapses together.
  • Interpersonal and social rhythm therapy (IPSRT) stabilizes daily rhythms, especially sleep, meals, and social contact, which are closely tied to mood shifts.

Supportive therapy, a steady relationship with a clinician for problem-solving and encouragement, is also widely used alongside these.

The numbers here are encouraging. A 2021 JAMA Psychiatry review by Miklowitz and colleagues pooled 39 randomized trials with 3,863 participants. Structured psychotherapy added to medication was associated with fewer recurrences than medication plus a control treatment, and family or group psychoeducation did better than individual psychoeducation. For a closer look at each approach, see our guide to supportive therapy for bipolar disorder.

Can bipolar disorder be treated without medication?

Short answer: the research supports therapy and routine changes added to medication, not in place of it. Every trial in the 2021 JAMA Psychiatry review compared medication plus psychotherapy with medication plus a control treatment. None tested therapy alone as a replacement.

That doesn't make the non-medication side minor. It's where much of the day-to-day work happens. As part of a full treatment plan, these habits help:

  • Regular sleep and wake times. AAFP lists sleep hygiene among active lifestyle approaches and names circadian disruption, such as shift work, as an environmental trigger.
  • Avoiding alcohol and drugs. Alcohol and drugs such as cocaine can trigger manic symptoms, and AAFP lists substance use among the things to monitor in ongoing care.
  • Tracking early warning signs. A simple mood and sleep log can show a shift days before it becomes an episode.
  • Managing stress. Psychosocial stress is a known trigger of both manic and depressive symptoms, according to AAFP.
  • Keeping a daily rhythm. Consistent meals, activity, and social contact are the backbone of IPSRT.

If you're thinking about reducing or stopping medication, talk it through with your psychiatrist first. NIMH advises against stopping a prescribed medication without your provider's help, even if you feel better; a provider can lower the dose slowly and safely.

Bipolar I vs. bipolar II: does the most effective treatment differ?

Bipolar I Disorder involves at least one manic episode, which can include psychosis. Bipolar II Disorder involves hypomania, a milder elevated state, along with major depressive episodes. In bipolar II, depression is often what people live with most.

The core principles are shared: medication matched to the phase, therapy added on top, and long-term follow-up. The choices shift with which episodes dominate. AAFP notes that antidepressant monotherapy is contraindicated in bipolar I, mania, and mixed episodes, so the medication conversation looks a little different for each type. Some conditions can look similar to bipolar disorder at first glance; our article on BPD vs. bipolar explains one common source of confusion.

What makes treatment work over the long term

The right medication and the right therapy only work if the plan holds together over years. Over the long term, a few practical things make a large difference:

  • Staying in treatment. AAFP lists treatment adherence among the core parts of ongoing management. Side effects, cost, or simply feeling better are all common reasons people stop, and each one is worth raising with the care team.
  • Watching physical health. Some medications affect the body as well as mood. NIMH notes that people taking atypical antipsychotics may need regular monitoring of weight, glucose, and lipid levels, and lithium requires blood tests.
  • One plan, not three. When the psychiatrist, therapist, and primary care doctor share information, side effects get caught and changes don't conflict.
  • Bringing family in. Relatives often notice an early shift before the person does. The evidence for family psychoeducation points the same way.

When weekly appointments are not enough

Outpatient care, with a psychiatrist and therapist seen every week or few weeks, works for many people. But not during a hard stretch. An IOP (Intensive Outpatient Program) adds several hours of structured treatment a few days a week while you live at home. A PHP (Partial Hospitalization Program) is more intensive, with treatment most of the day on most weekdays. Inpatient care is for times when safety can't be maintained at home. Learn how our intensive outpatient program and partial hospitalization program work, or compare them in PHP vs. IOP.

When to seek help now

Some signs mean an episode may be starting and the care team should hear about it soon. NIMH lists symptoms such as a decreased need for sleep, racing thoughts, and an excessive appetite for pleasurable activities. Others point the other way: sleeping too much and a lack of interest in almost all activities.

Thoughts of self-harm or suicide need help the same day. If you or someone you love is in crisis, call or text 988, or see the FAQ below.

How we treat bipolar disorder at Amae Health

Bipolar disorder is one of the conditions we specialize in at Amae Health. We treat adults 18 and older with severe mental illness (SMI) in in-person outpatient clinics, with care led by psychiatrists. Your team works under one roof: psychiatrists, therapists, primary care physicians, dietitians, health coaches, peer mentors, and clinical care coordinators, all on one treatment plan. When more structure is needed, we offer PHP and IOP. Our tagline, Beyond Care. Towards Cure., means aiming for remission and recovery, not stopping at stability.

To start, see bipolar disorder treatment at Amae or call 1-888-860-2825. When you call, it helps to have a list of your current medications and past treatments ready.

Key takeaways

  • The most effective treatment for bipolar disorder is usually medication plus psychotherapy, continued long term.
  • Treatment depends on the phase: acute mania, bipolar depression, and maintenance each call for different choices.
  • Antidepressants are typically given alongside a mood stabilizer, not on their own.
  • Therapy and daily routines work best added to medication, not as a replacement.
  • Staying in treatment, monitoring physical health, and stepping up the level of care when needed keep a plan working.

Frequently Asked Questions

What is the most effective treatment for bipolar disorder?

For most people, it's a combination of medication and psychotherapy, adjusted to the phase of illness and continued over the long term. NIMH notes that bipolar disorder usually requires lifelong treatment. Therapy added to medication is linked to fewer recurrences.

What is the first-line treatment for bipolar disorder?

Mood stabilizers, such as lithium and certain anticonvulsants, and some atypical antipsychotics. The choice depends on whether the person is in a manic, mixed, or depressive episode, or in maintenance. A psychiatrist weighs the phase, history, and side effects.

What is the most effective treatment for bipolar 2?

The same principles apply: medication, therapy, and long-term follow-up. Depression is often the main focus in bipolar II. Antidepressants are typically prescribed together with a mood stabilizer to reduce the risk of switching into mania.

Is it possible to recover from bipolar disorder?

Bipolar disorder is a long-term condition, but many people reach long periods of stability with ongoing treatment. Recovery here means fewer and milder episodes and a life that works on your terms. Staying in treatment is what protects that.

What is a good daily routine for someone with bipolar disorder?

Regular sleep and wake times, consistent meals, daily activity, and a simple mood log. This idea is at the center of interpersonal and social rhythm therapy. A routine supports treatment; it doesn't replace it.

What should I do if someone with bipolar disorder is in crisis?

Call or text 988 to reach the 988 Suicide and Crisis Lifeline, available 24/7. If someone is in immediate danger, call 911. Stay with the person if it's safe to do so.

Reccomended for you

# min read

TMS vs Ketamine and Spravato for Treatment-Resistant Depression

By

Sonia Garcia

|

October 5, 2026

If you are comparing TMS, ketamine, and Spravato for depression, you have probably reached the point where standard antidepressants have not done enough. All three are evidence-based options for treatment-resistant depression, and beyond that they have little in common. TMS is a course of magnetic stimulation delivered while you sit awake in a chair. Ketamine is an anesthetic given by IV, used off-label for depression. Spravato is a nasal spray made from esketamine, one of the two mirror-image forms that make up ketamine, with its own FDA approval and its own rulebook.

‍

None of the three is universally better. They differ in mechanism, speed, setting, and monitoring, and the right one depends on your clinical history and how you respond. Treatment-resistant depression generally means depression that has not adequately improved after at least two antidepressants taken at a proper dose for long enough, and that is the group where all three are most often used.

What Is TMS?

Transcranial magnetic stimulation uses a coil placed against the scalp to deliver focused magnetic pulses to the left dorsolateral prefrontal cortex, a region involved in mood regulation. The FDA first cleared TMS for major depressive disorder in 2008, according to the National Institute of Mental Health. It is delivered in an office, with no anesthesia and no medication.

‍

Our standard TMS course runs 20 to 30 daily sessions over four to six weeks, each 30 to 40 minutes long. You stay awake throughout and drive yourself home afterward. In real-world outcome data from 42 U.S. practices, more than half of patients with medication-resistant depression responded to a standard course, and more than a third reached remission.

What Is Ketamine Therapy?

Ketamine has been an FDA-approved anesthetic since 1970. Its use for depression is off-label: prescribed for a purpose the FDA has not formally approved, which is legal and common in medicine but leaves the safeguards less standardized. It is usually given as an IV infusion in a monitored clinic, as a series of sessions over a few weeks.

‍

Ketamine blocks the NMDA receptor, a glutamate receptor, rather than acting on serotonin like standard antidepressants, and that difference is thought to explain its speed. In a landmark 2006 trial, 18 people with treatment-resistant depression received a single infusion of 0.5 mg/kg, and their symptoms improved significantly within 110 minutes. By the next day, 71% had responded and 29% were in remission. One week later, 35% still met the response threshold. Rapid, real, and often short-lived.

‍

The catch is in the monitoring. Ketamine causes dissociation, a sense of detachment from your body or surroundings, plus sedation and blood pressure rises during and after the infusion, so you are observed until those effects pass and cannot drive that day. In a 2017 consensus statement in JAMA Psychiatry, an American Psychiatric Association task force found the evidence for rapid antidepressant effects convincing but the studies small, the longer-term efficacy data lacking, and the safety data on repeated dosing limited.

What Is Spravato (Esketamine)?

Ketamine is a mixture of two mirror-image molecules. Spravato is esketamine, one of those two, delivered as a nasal spray. Unlike IV ketamine, it has FDA approval for depression. The original approval came in March 2019 for treatment-resistant depression alongside an oral antidepressant, a second indication followed for adults with major depressive disorder and acute suicidal thoughts or behavior, and in January 2025 the FDA approved Spravato as a standalone monotherapy for treatment-resistant depression, with no oral antidepressant required, per the current prescribing information.

‍

That approval comes with a rulebook. Spravato can only be given at a setting certified under a Risk Evaluation and Mitigation Strategy (REMS) program: you take the spray under supervision, you are monitored for at least two hours before an assessment clears you to leave, and you cannot drive until the next day after a restful sleep. Its label carries a boxed warning for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors in younger patients.

‍

So is Spravato the same as ketamine? Related, not identical: same molecular family, same receptor, similar rapid onset and dissociative effects, but a different route, a formal FDA indication, and mandatory monitoring rules that off-label ketamine does not carry. For most people comparing TMS vs Spravato, those rules and insurance coverage are the practical differences that matter.

TMS vs Ketamine vs Spravato: Side-by-Side Comparison

Feature TMS IV ketamine Spravato (esketamine)
Mechanism Magnetic pulses stimulate the prefrontal cortex NMDA receptor antagonist, given intravenously NMDA receptor antagonist, nasal spray
FDA status Cleared for MDD (2008) and OCD (2018) Approved as an anesthetic; off-label for depression Approved for TRD (2019 with an oral antidepressant; 2025 as monotherapy) and for MDD with acute suicidal ideation
Onset Gradual, across a multi-week course Hours to days Hours to days
Session format 30 to 40 minutes, awake, in an office Infusion in a monitored clinic Self-administered spray under supervision in a certified setting
Monitoring None after the session Observed during and after the infusion At least two hours after each dose
Driving Drive yourself home Not that day Not until the next day
Typical course 20 to 30 daily sessions over 4 to 6 weeks A series of infusions over several weeks, then maintenance as needed Twice a week for the first four weeks, then weekly, with later dosing individualized
Common side effects Scalp discomfort, headache Dissociation, sedation, blood pressure rise, nausea Dissociation, dizziness, nausea, sedation, vertigo, raised blood pressure

Onset and Duration of Effect

Speed is the clearest dividing line. TMS builds gradually, and many people do not notice a clear change until the second or third week or later. Ketamine and Spravato can shift symptoms within hours to days.

‍

Speed and staying power are different things. Ketamine's effect after a single infusion often fades within a week or two, which is why it is given as a series with maintenance dosing. Spravato starts at twice a week and tapers, with the need for continued treatment reassessed along the way. Research on durability is still developing for all three, and none should be described as permanent.

Side Effects and Safety Considerations

TMS side effects are local and short-lived: scalp discomfort where the coil sits, headache, and sometimes brief lightheadedness or facial muscle twitching during the pulses. These usually settle within the first week, and because nothing enters the bloodstream there is no weight gain, sexual dysfunction, or sedation. Seizure is the one serious risk, exceedingly rare, and TMS is not used in people with a seizure history, metal in the head, or implanted electronic devices.

‍

Ketamine and Spravato share a different profile. The most common reactions to Spravato in trials were dissociation, dizziness, nausea, sedation, vertigo, numbness, anxiety, lethargy, increased blood pressure, vomiting, feeling drunk, and headache. Those effects peak in the hours after dosing, which is what the monitoring window is for, and both drugs carry a potential for misuse that shapes who is a candidate. Each option has its own screening, and a contraindication to one does not rule out the others.

Cost and Insurance

For TMS, most commercial insurers cover treatment for major depressive disorder once eligibility criteria are met, typically a confirmed diagnosis and documented antidepressant trials without adequate relief. Prior authorization is standard. For TMS we take all commercial insurance plans, cash pay is available, and authorization is something our intake team manages for you.

‍

Spravato is more commonly covered than off-label ketamine because it has an FDA indication insurers can write criteria around, though prior authorization and documentation of failed antidepressant trials are typically required. Ketamine infusion coverage varies widely, and many clinics are self-pay. Published cost estimates vary so much by dose, frequency, and insurance status that a single dollar figure would mislead; ask each provider and your insurer directly.

Can These Treatments Be Combined?

Sometimes, and the research is early. A 2024 systematic review found six published studies on combining TMS with ketamine, mostly case reports plus one retrospective review and one small pilot, and reported substantial and sustained improvement with generally mild side effects. The authors also said the designs were too varied and the samples too small for firm conclusions, and called for randomized trials.

‍

In practice, TMS and Spravato are sometimes used one after the other. Combining any of these is a clinical judgment a psychiatrist makes from your history, not a general recommendation, and the more common pattern is to use one, assess the response, then decide.

Choosing Between Them: What Influences the Decision

A psychiatrist weighing these options usually works through a short list:

‍

  • Treatment history. Which antidepressants, at what doses, for how long, and whether psychotherapy has been tried.
  • How urgently relief is needed. When symptoms are severe or suicidal thoughts are present, a faster-acting option may take priority, alongside care for suicidal thoughts.
  • Tolerance for the experience. Dissociation and a two-hour monitored window, versus a daily half-hour appointment for several weeks with no drug effects.
  • Practical constraints. Whether you can get to daily sessions, whether someone can drive you home after Spravato or ketamine, and what your insurance will authorize.
  • Health factors. Seizure history, metal implants, blood pressure, and any history of substance misuse each rule options in or out.
  • What else is in place. Any of the three works better inside ongoing psychiatric care and therapy than as a standalone fix.

Making the Decision With an Integrated Care Team

TMS, ketamine, and Spravato are tools, and tools do their best work inside a plan: a psychiatrist who knows your history, a therapist working alongside the biological treatment, and a team that notices when the plan needs to change.

‍

That is how we work. At Amae, our one-team care model combines psychiatry, therapy, primary care, and peer support, and TMS and Spravato are available through our Los Angeles and Bay Area clinics as part of that care. If you have been through the antidepressant cycle and want a clear, unhurried look at what comes next, talk with an Amae psychiatrist about your options. If you are in crisis or thinking about suicide, call or text 988 now.

Frequently Asked Questions

What is the difference between TMS and ketamine for depression?

TMS stimulates the brain with magnetic pulses over a course of daily outpatient sessions, with no drug, no sedation, and no monitoring afterward. Ketamine is a medication that acts on NMDA receptors, given by infusion or, as esketamine, by nasal spray, with monitored sedation and dissociation and often faster but shorter-lived effects.

Is Spravato the same as ketamine?

Related but not identical. Spravato is esketamine, the S-enantiomer of the ketamine molecule, delivered as an FDA-approved nasal spray under a required monitoring program. Ketamine infusions use the full ketamine compound and are prescribed off-label for depression, without an FDA indication for that use.

Is Spravato only approved with an antidepressant?

Not anymore. The original 2019 approval was for use alongside an oral antidepressant, and in January 2025 the FDA also approved Spravato as a standalone monotherapy for adults with treatment-resistant depression. Whether it is used alone or with an antidepressant is a decision your psychiatrist makes based on your situation.

Which works faster, TMS or Spravato?

Spravato. Esketamine and ketamine can produce symptom change within hours to days, while TMS builds gradually across a four-to-six-week course. Faster onset does not mean more durable improvement, and both durability and side effects belong in the comparison.

Can TMS and Spravato be used together?

Sometimes, as a clinical decision made with a psychiatrist based on your individual history. Both can be part of a broader treatment-resistant depression plan alongside medication and therapy, and the evidence on combining them is still early.

Is ketamine or Spravato covered by insurance?

Spravato is more commonly covered, because it has an FDA indication insurers can build criteria around, though prior authorization and proof of failed antidepressant trials are usually required. Coverage for off-label ketamine infusions varies widely and is often self-pay. Confirm with the provider and your insurer before starting.

‍

Citations

  1. National Institute of Mental Health. Brain Stimulation Therapies. https://www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapies
  2. Carpenter LL, Janicak PG, Aaronson ST, et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depression and Anxiety. 2012. https://pubmed.ncbi.nlm.nih.gov/22689344/
  3. Zarate CA, Singh JB, Carlson PJ, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry. 2006. https://pubmed.ncbi.nlm.nih.gov/16894061/
  4. Sanacora G, Frye MA, McDonald W, et al. A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry. 2017. https://pubmed.ncbi.nlm.nih.gov/28249076/
  5. U.S. Food and Drug Administration. Drugs@FDA: SPRAVATO (esketamine), NDA 211243, approval history. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211243
  6. U.S. Food and Drug Administration. SPRAVATO (esketamine) nasal spray prescribing information, revised January 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211243s016lbl.pdf
  7. Arubuolawe OO, Folorunsho IL, Busari AK, et al. Combination of transcranial magnetic stimulation and ketamine in treatment-resistant depression: a systematic review. Cureus. 2024. https://pubmed.ncbi.nlm.nih.gov/39156335/
  8. 988 Suicide and Crisis Lifeline. https://988lifeline.org

‍

# min read

Understanding the Negative Effects of Social Isolation

By

Sonia Garcia

|

October 25, 2026

Days go by without a real conversation. Invitations stopped coming, or you stopped saying yes. At first it felt like rest. Now it feels like a wall. If you've been wondering what isolation is doing to you, or to someone you love, the research has a fairly clear answer: the negative effects of social isolation reach mood, the heart, sleep, and memory, and they build over time.

The good news is that connection works in both directions. The same research that shows the harm also suggests that rebuilding contact, even in small steps, matters.

What is social isolation?

The CDC defines social isolation as not having relationships, contact with, or support from others. It's something you can count: how often you talk to people, whether anyone would help in a crisis, whether you're part of any group.

Loneliness is different. It's the feeling of being alone or disconnected, the gap between the connection you have and the connection you want. You can be isolated without feeling lonely, and you can feel lonely in a room full of friends. The two often feed each other, and both carry health risks.

They're also common. According to the CDC, about 1 in 3 U.S. adults report feeling lonely, and about 1 in 4 report not having social and emotional support.

Who is most at risk?

The CDC lists several factors that raise the risk of isolation and loneliness, including:

  • A chronic physical illness, disability, or a psychiatric or depressive condition
  • Divorce, unemployment, or the loss of a loved one
  • Living in a rural area, limited transportation, or language barriers
  • Being a victim of violence or abuse
  • Older age, living alone, low income, and being a young adult

Mental health conditions sit on both sides of the equation. Depression, anxiety, and psychosis can make people pull away, and isolation can make those conditions worse.

What does isolation do to a person mentally?

Depression

In a 2017 population-based study in PLOS ONE of 1,919 adults in Singapore, weak connections with relatives and friends, and loneliness, were both associated with more depressive symptoms, even after accounting for age, gender, employment, and other factors. Loneliness had the strongest association. The study was cross-sectional, so it shows a link rather than proving which came first, but the pattern matches what the CDC reports: isolation and loneliness raise the risk of depression and anxiety.

Suicidality and self-harm

The CDC also lists suicidality and self-harm among the health risks of isolation and loneliness. If you or someone you know is having thoughts of suicide, call or text 988, the Suicide & Crisis Lifeline. Reaching out is a form of connection too.

Withdrawal as an early warning sign

Sometimes isolation is a symptom rather than a cause. The NIMH lists withdrawing socially and spending much more time alone among the warning signs that can appear before a first episode of psychosis. Pulling away from people can also be a sign of depression, something we describe in what severe depression feels like. A sudden or growing withdrawal, especially in a teen or young adult, deserves attention. With psychosis, early care makes a difference. Read more about how we treat psychosis.

Effects of social isolation on the body

Heart disease and stroke

A 2022 scientific statement from the American Heart Association reviewed the research on isolation and cardiovascular health. It cited a meta-analysis in which social isolation or loneliness was linked to a 29% higher risk of coronary heart disease and a 32% higher risk of stroke. The authors also noted that the effect estimates are small and that unmeasured factors may play a role.

Stress hormones and inflammation

Isolation shows up in the body's stress systems. In a 2021 study in Psychoneuroendocrinology of 314 adults from the Midlife in the United States (MIDUS) study, living alone was associated with a flatter daily cortisol rhythm and higher C-reactive protein, a marker of inflammation. Loneliness was separately associated with higher levels of another inflammatory marker, IL-6.

A larger 2025 study in Nature Human Behaviour of 42,062 UK Biobank participants identified blood proteins linked to isolation and loneliness. Many were involved in inflammation and immune responses, and more than half were linked to later heart disease, type 2 diabetes, stroke, and death.

Earlier death

A 2015 meta-analysis in Perspectives on Psychological Science found that social isolation was associated with a 29% higher likelihood of death, loneliness with 26%, and living alone with 32%, after controlling for other factors. The authors concluded the risk is comparable to other well-established risk factors for mortality.

Effects on memory and the brain

In the English Longitudinal Study of Ageing, researchers followed 11,233 adults aged 50 and older over six assessments, two years apart. Isolation was associated with faster memory decline, particularly in men who were highly isolated at the start and in women whose isolation grew over time. The analysis suggested isolation contributed to memory decline, rather than poor memory causing isolation.

Dementia risk follows a similar pattern. In a nine-year U.S. study of 5,022 older adults published in the Journal of the American Geriatrics Society, being socially isolated was associated with a 28% higher risk of developing dementia, with no significant difference by race or ethnicity.

Signs that isolation is taking a toll

  • Going days without a meaningful conversation
  • Declining invitations or avoiding calls and messages
  • Losing interest in activities you used to enjoy
  • Sleep changes, low energy, or changes in appetite
  • Persistent sadness, irritability, or feeling numb
  • Neglecting self-care or your home
  • Feeling like no one would notice if you disappeared

The last one is important. Feeling invisible or like a burden is a warning sign, and it's a reason to reach out today, or to call or text 988.

Can the effects of social isolation be reversed?

Much of the research is observational, so it shows risk rather than a guaranteed path back. But the ageing study found the strongest memory effects in people whose isolation was high or growing, which suggests the pattern over time matters. Reconnecting helps at any point, and the earlier the better.

Practical steps that help people rebuild contact include:

  • Start small. One text, one short call, one coffee. Consistency matters more than size.
  • Schedule it. Put regular check-ins with a friend or family member on the calendar.
  • Join something structured. A class, volunteer role, faith community, or interest group gives you a reason to show up.
  • Mix in-person and digital. Video calls help, but protect some in-person time too.
  • Lower the bar. You don't need a deep conversation. Being around people counts.

If depression, anxiety, or another condition is what's keeping you isolated, treating it often makes reconnection possible in a way willpower alone doesn't.

When to get professional help

Talk to a mental health professional if isolation comes with persistent low mood, intense anxiety, loss of interest, neglect of basic self-care, or hopelessness that lasts for weeks. Get help sooner if someone is withdrawing alongside confused thinking, unusual beliefs, or hearing or seeing things others don't.

At Amae Health, our clinics specialize in conditions including Major Depressive Disorder, bipolar disorder, schizophrenia, and first-episode psychosis, where withdrawal is often part of the picture. Our care teams include psychiatrists, therapists, primary care physicians, care coordinators, and peer mentors who help with counseling and life skills. Group therapy is part of care too. For more on levels of care, see inpatient vs. outpatient mental health treatment. If reaching out feels hard, our guide on how to ask for help when depressed may help.

Frequently asked questions

What is the difference between social isolation and loneliness?

Social isolation is an objective lack of relationships, contact, or support. Loneliness is the subjective feeling of being alone or disconnected. You can have one without the other, and both are linked to health risks.

What does social isolation do to a person?

Research links isolation to more depressive symptoms, higher risk of heart disease and stroke, changes in stress hormones and inflammation, faster memory decline, higher dementia risk, and earlier death. Most of these findings are associations, and the risks build over time.

Why is isolation bad for your mental health?

Isolation removes support, routine, and the everyday contact that helps regulate mood. The CDC lists depression, anxiety, and suicidality among its health risks. Isolation can also be a symptom of depression or psychosis, which makes it a signal to notice.

How can I tell if someone is isolating because of a mental health condition?

Watch for withdrawal that's new or growing, combined with changes like low mood, poor self-care, confused thinking, or unusual beliefs. Ask directly and kindly how they're doing, and encourage an evaluation if the changes persist.

Key takeaways

  • Social isolation is a lack of contact and support. Loneliness is the feeling of disconnection. Both carry health risks.
  • Research links isolation to depression, heart disease and stroke, inflammation, memory decline, dementia, and earlier death.
  • Withdrawal can also be an early sign of depression or psychosis.
  • Small, regular steps toward connection help, and treating an underlying condition can make reconnecting possible.

If isolation is part of a bigger pattern of depression, mood swings, or changes in thinking, for you or someone you love, request an intake appointment. Our team will explain how an evaluation works and what the first visit involves.

# min read

Bipolar Disorder Supportive Therapy: How It Helps Stabilize Mood

By

Sonia Garcia

|

May 18, 2026

Bipolar disorder changes the weather inside a life. Mood swings disrupt work, sleep, relationships, and the sense that next month will look anything like this one. The emotional exhaustion of cycling through episodes and the strain those episodes put on close relationships are part of why so many patients describe bipolar disorder as harder to live with than almost any other condition they know. Medication is usually the foundation of treatment. But medication alone is rarely enough. Bipolar disorder supportive therapy is one of several psychotherapy approaches that sit alongside medication to turn stability into an actual life.

‍

This guide explains what supportive therapy is, how it fits alongside other therapies, and what kind of help may improve day-to-day stability.

What Is Supportive Therapy For Bipolar Disorder?

Supportive therapy is a psychotherapy approach built around emotional support, trust, validation, and practical coping. It does not focus on deep analysis of the unconscious, and it is not a structured skills protocol. It is the kind of therapy where a clinician listens carefully, helps you make sense of what you are feeling and going through, reinforces what is working, and helps you solve the next problem in front of you.

‍

Supportive therapy is almost always part of a broader treatment plan for bipolar disorder, not a replacement for psychiatric care. Most people combine it with medication management, and many eventually layer in more structured approaches like CBT or family-focused therapy.

What Techniques Are Used in Bipolar Disorder Supportive Therapy

The practical tools a supportive therapist uses include:

‍

  • Emotional validation that acknowledges the real weight of what the person is experiencing
  • Active listening that slows down and surfaces what is actually going on, not just the surface complaint
  • Psychoeducation about the illness cycle, warning signs, and what to expect
  • Problem-solving on concrete day-to-day stressors, from a difficult conversation to a medication side effect
  • Strengthening insight about mood patterns and personal triggers
  • Reinforcing engagement in the full treatment plan, including appointments and medication

How Supportive Therapy Helps People With Bipolar Disorder

Emotional Support During Mood Instability

Mood episodes are disorienting. A depressive stretch can last weeks, a hypomanic period can feel like the most productive month of your life until it crashes, and a mixed episode can fold both into the same week. Supportive therapy gives a person somewhere to bring that weight, week after week, with someone who understands what bipolar disorder looks like from the inside. That consistency alone steadies many patients through the worst stretches.

Building Coping Skills And Daily Stability

The practical work of staying well with bipolar disorder is mostly about routines. Supportive therapy helps people build and protect them:

‍

  • Consistent sleep and wake times, because sleep disruption is a common trigger
  • Strategies for stress management when life gets loud
  • Conflict management skills for relationships under strain
  • Recognizing early warning signs of an episode so they can be interrupted

Supporting Medication Adherence And Ongoing Care

Medication is the foundation of bipolar treatment. But it can also be hard to stay on. Side effects, the feeling of missing hypomanic energy, the belief that symptoms will not return, and plain forgetfulness all contribute to the high discontinuation rates that research keeps finding. Supportive therapy gives people a place to talk honestly about their fears and frustrations with medication, think through side effects with a trusted clinician, and stay engaged when the usual instinct would be to drop out.

Supportive Therapy vs. Other Therapy Approaches

Supportive therapy is one of several psychotherapy approaches with evidence for bipolar disorder. A quick comparison:

Therapy Primary focus Typical use in bipolar disorder
Supportive therapy Emotional support, coping, engagement Early in treatment, during stabilization, alongside medication
Cognitive behavioral therapy (CBT) Identifying and reshaping unhelpful thought patterns Managing depressive episodes, relapse prevention
Dialectical behavior therapy (DBT) Emotion regulation, distress tolerance, interpersonal skills High emotional reactivity, self-harm risk, co-occurring BPD
Family-focused therapy (FFT) Communication and relapse planning with family Adolescents and adults with close family involvement
Interpersonal and social rhythm therapy (IPSRT) Stabilizing sleep, routines, and interpersonal patterns Rhythm disruption, relationship stressors, mood cycling

A large systematic review of 39 randomized trials of adjunctive psychotherapy for bipolar disorder found that family-focused, cognitive behavioral, and psychoeducational therapies reduced episode recurrence compared with usual treatment (Miklowitz et al., JAMA Psychiatry, 2021).

When Other Therapies May Be Added

Supportive therapy is often the right starting point, especially after a new diagnosis or during stabilization. Over time, many patients add a more structured approach:

‍

  • CBT for persistent depressive symptoms or to build relapse-prevention skills
  • DBT for patients with heavy emotional reactivity or co-occurring BPD features
  • IPSRT for people whose episodes are tied to disrupted sleep and routines
  • Family-focused therapy when relationship dynamics are shaping the illness course

‍

The choice depends on symptoms, goals, and what the person actually needs at that stage. A skilled clinician will adjust the approach as the picture changes.

What To Expect In Bipolar Disorder Supportive Therapy

Sessions are usually 45 to 50 minutes and are typically weekly at the start. The work is conversational rather than homework-driven. A session might open with what happened that week, look at mood patterns since the last visit, surface any new stressors, and end with a small plan for the week ahead.

‍

The clinician will pay attention to warning signs: sleep changes, energy shifts, spending or relationship patterns, and medication side effects. Over time, a person in supportive therapy often becomes much better at tracking their own mood, which makes the intervals between episodes longer and the episodes themselves shorter.

Who May Benefit Most

Supportive therapy tends to help most for:

‍

  • People newly diagnosed who need to make sense of what bipolar disorder is and what the next year can look like
  • People adjusting to treatment who are figuring out medication, routines, and how to communicate about the illness
  • People navigating the emotional fallout of a recent episode, including shame, regret, or strain with family
  • People in long-term stabilization who want a steady clinician presence without intensive protocols

‍

It is less of a match for patients who need heavy skills training for severe emotion dysregulation or those in active crisis, where higher levels of care are indicated.

When To Seek Professional Help For Bipolar Disorder

A few questions to ask yourself:

‍

  • Are mood episodes interfering with work, school, or close relationships?
  • Has your sleep pattern changed significantly for more than a week?
  • Are you making impulsive decisions that later feel hard to explain?
  • Is someone close to you saying your behavior feels out of character?
  • Are you having thoughts of self-harm or suicide?

‍

If the answer to any of these is yes, it is worth calling a clinician. For immediate safety concerns, call 988 for the Suicide and Crisis Lifeline.

Bipolar Disorder Care At Amae Health

At Amae Health, we support individuals battling bipolar disorder. Our approach is integrated: psychiatrists, therapists, primary care providers, dietitians, health coaches, peer mentors, and clinical care coordinators all work from one shared treatment plan. That structure matters for bipolar disorder, because the condition touches sleep, physical health, medication, and relationships at the same time, and fragmented care usually misses something.

‍

If bipolar symptoms are disrupting daily life for you or someone you love, we can help with evaluation, treatment planning, and ongoing support. Learn more about our bipolar disorder care, read our guide to the most effective treatments for bipolar disorder, or call 1-888-860-2825 to start the conversation.

‍

Citations

  1. Miklowitz et al., "Adjunctive Psychotherapy for Bipolar Disorder: A Systematic Review and Component Network Meta-analysis," JAMA Psychiatry, 2021. Tier 1 (peer-reviewed).

‍